News Search & Analytics
US Edition
Minimum 3 characters required!!
Report Based On Past 7 Days Data
13
Total Articles
10
Total Publisher Covering articles
5
Highest On 2017-03-23
0
Articles Got Popular On Social Media
advanced cancer treatment found in Articles in last 7 Days

Top Articles

BRIEF-FDA approves new, targeted treatment for Bladder Cancer
-Reuters - Wed May 18 11:14:20 EDT 2016
May 18 U.S. FDA * U.S. FDA approves new, targeted treatment for bladder cancer * Tecentriq Approved For Treatment Of Patients With Locally Advanced Or Metastatic Urothelial Carcino...
Blood biopsy: Releasing cancer cells for better analysis
-PHYS ORG - Thu Apr 28 03:16:35 EDT 2016
The device captures cancer cells from a blood sample. When a cold solution runs through the device, it releases the cancer cells for further study. Credit: Hyeun Joong Yoon, Apoorv...
Study May Boost Use of Merck Lung-Cancer Drug
-The Wall Street Journal - Sun Oct 09 20:13:37 EDT 2016
Patients with advanced lung cancer who took Merck & Co.’s immune-boosting drug Keytruda as their first treatment lived longer on average than those who received chemotherapy in...
Dec 7 Puma Biotechnology Inc * Puma Biotechnology - Median p95HER2 levels were higher in samples from patients who achieved a pCR with neratinib * Puma Biotechnology presents resul...
FDA OKs new Novartis drug for type of advanced --- cancer
-The Seattle Times - Mon Mar 13 14:09:26 EDT 2017
U.S. regulators have approved a new drug as an initial treatment for postmenopausal women with a type of advanced --- cancer. The drug, called Kisqali, is a pill that works to s...
Immunotherapy Shows Promise In Head And Neck Cancer Treatment
-Immortal News - Sun Oct 09 11:16:04 EDT 2016
A clinical trial has confirmed that the immunotherapy drug nivolumab has the potential to be a “game-changer” in head and neck cancer, according to a study presented at the Europea...
ZURICH Roche Holding AG said on Monday the U.S. Food and Drug Administration has granted priority review for atezolizumab for treating people with a specific type of lung cancer. T...
Aug 5 Bristol-myers Squibb Co : * Bristol-Myers Squibb announces top-line results from checkmate -026, a phase 3 study of Opdivo (nivolumab) in treatment-naïve patients with advanc...
CINCINNATI, Dec. 14 (UPI) -- Researchers the University of Cincinnati College of Medicine have generated multifunctional RNA nanoparticles that could overcome treatment-resistant b...
(Reuters) - Pennsylvania Governor Tom Wolf said on Friday he has been given a clean bill of health after undergoing treatment for prostate cancer. Wolf announced in February he had...
ATLANTA - Month date, 2016-While use of the standard therapy leading to the best outcome against locally advanced rectal cancer has increased over the past decade, only half of pat...
LOS ANGELES, Oct. 17 (UPI) -- Administering blood tests to lung cancer patients at the time of diagnosis may be able to hasten treatment decisions, researchers suggest in a new stu...
Pfizer Strikes Deal to Buy Medivation for Nearly $14B
-U.S. News - Mon Aug 22 05:12:47 EDT 2016
NEW YORK (AP) — Pfizer will pay about $14 billion in cash for the cancer drug company Medivation, a deal that will add the pricey late-stage prostate cancer treatment Xtandi to its...
U.S. FDA approves Bristol-Myers' Opdivo for bladder cancer
-Reuters - Thu Feb 02 10:25:13 EST 2017
The U.S. Food and Drug Administration on Thursday expanded the use of Bristol-Myers Squibb Co's Opdivo to include treatment of urothelial carcinoma, the most common type of bladder...
Researcher finds key to drug resistant bowel cancer
-Medical Xpress - Tue Nov 08 16:15:44 EST 2016
Blocking a molecule could bypass bowel cancer's defence against the drug cetuximab, according to new research presented at the National Cancer Research Institute (NCRI) Cancer Conf...
Clovis Oncology Inc. shares ticked higher after hours Tuesday following a big jump in the regular session as the Food and Drug Administration accepted a marketing application for t...
ZURICH Roche said on Tuesday its lung cancer drug Alecensa (alectinib), developed by its Genentech unit, received a second breakthrough therapy designation (BTD) from the U.S. Food...
Oct 7 Clovis Oncology Inc : * Prescription drug user fee act (PDUFA) date is February 23, 2017 * Clovis Oncology presents efficacy and safety data from new drug application (NDA) p...
Dec 19 Source: U.S. Food and Drug Administration * U.S. FDA grants accelerated approval to new treatment for advanced ovarian cancer * U.S. FDA says also granted the Rubraca applic...
LONDON, Sept. 14 (UPI) -- A blood test may be enough to determine if prostate cancer treatment is working, and allow doctors to change treatment faster if it isn't effective. A 30 ...
FRIDAY, April 15, 2016 -- Despite the increasing use of a standard therapy for rectal cancer in the United States, only slightly more than half of patients receive it, a new study ...
Head and neck cancer drug 'game changer'
-BBC News - Tue Apr 19 05:37:40 EDT 2016
A new type of cancer drug that wakes up the patient's own immune system to fight tumours could be a game changer for tackling aggressive head and neck cancers, say experts. Trial r...
BRIEF-Merck says FDA accepts two SBLAs for Keytruda
-Reuters - Fri Feb 03 02:04:40 EST 2017
Feb 3 Merck & Co Inc * FDA accepts two SBLAs for Merck's Keytruda (pembrolizumab) for locally advanced or metastatic urothelial cancer in cisplatin-ineligible first-line and s...
Many with Advanced Lung Cancer Don't Get Treatments That Might Help
-MedlinePlus - Mon Jan 23 04:14:20 EST 2017
FRIDAY, Jan. 20, 2017 (HealthDay News) -- Many U.S. patients with late-stage lung cancer do not receive treatments that could prolong their lives, a new study finds. Researchers at...
April 29 Roche Holding AG * Says CHMP recommends EU approval for Roche's Avastin in combination with Tarceva for patients with a specific type of advanced lung cancer * Says recomm...
PET scans guiding chemo boosts remission for Hodgkin patients
-Medical Xpress - Mon Apr 11 14:16:34 EDT 2016
Dr. Oliver Press, a SWOG member at Fred Hutchinson Cancer Research Center and the lead author of the JCO article, said the study is exciting because it's the first large-scale US t...
June 6 Clovis Oncology Inc : * No treatment-related deaths were reported * Nineteen patients (9%) discontinued treatment because of an adverse event. * Using prespecified 14% cuto...
Feb 2 Neurovive Pharmaceutical Ab * Neurovive's new generation of sanglifehrin-based compounds demonstrate potent inhibitory effects on human epatocellular cancer cells * Says prec...
FDA OKs new Novartis drug for type of advanced --- cancer
-The Brownsville Herald - Mon Mar 13 14:39:42 EDT 2017
Posted: Monday, March 13, 2017 3:13 pm Associated Press | U.S. regulators have approved a new drug as an initial treatment for postmenopausal women with a type of advanced --- c...
Men with metastatic prostate cancer have a surprisingly high rate of inherited mutations in DNA-repair genes, suggesting that all men with such advanced prostate cancer should be c...
Advertisement